Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James Angus Duncan Smith currently holds 48,157 shares of GENELABS TECHNOLOGIES INC /CA (GNLB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Angus Duncan Smith has been a net neutral trader of GNLB stock. They have purchased $0 and sold $0 worth of shares.
James Angus Duncan Smith's most recent insider trade was on Dec 31, 2007, when they sold 4,552 shares at $1.11 per share.
James Angus Duncan Smith serves as Executive at GENELABS TECHNOLOGIES INC /CA (GNLB). They have executed 5 insider transactions totaling $0 over their tenure at the company.
James Angus Duncan Smith holds the position of Executive at GENELABS TECHNOLOGIES INC /CA, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 21 years and currently hold a stake valued at $0.
James Angus Duncan Smith has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by James Angus Duncan Smith was on Jun 29, 2007, when they sold $15.6K worth of GNLB shares. This transaction involved 12,571 shares at $1.24 per share.
James Angus Duncan Smith currently owns 48,157 shares of GENELABS TECHNOLOGIES INC /CA (GNLB), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James Angus Duncan Smith's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James Angus Duncan Smith has 5 Form 4 filings on record as an insider at GENELABS TECHNOLOGIES INC /CA.
Set alerts for James Angus Duncan Smith and 40,000+ other insiders.